Brain atrophy and lesion load in a large population of patients with multiple sclerosis G Tedeschi, L Lavorgna, P Russo, A Prinster, D Dinacci, G Savettieri, ... Neurology 65 (2), 280-285, 2005 | 209 | 2005 |
Predictors of long–term clinical response to interferon beta therapy in relapsing multiple sclerosis V Tomassini, A Paolillo, P Russo, E Giugni, L Prosperini, C Gasperini, ... Journal of neurology 253, 287-293, 2006 | 143 | 2006 |
Caregiver quality of life in multiple sclerosis: a multicentre Italian study F Patti, MP Amato, MA Battaglia, M Pitaro, P Russo, C Solaro, M Trojano Multiple Sclerosis Journal 13 (3), 412-419, 2007 | 139 | 2007 |
Risk factors for uncontrolled hypertension in Italy E Degli Esposti, M Di Martino, A Sturani, P Russo, C Dradi, S Falcinelli, ... Journal of human hypertension 18 (3), 207-213, 2004 | 107 | 2004 |
Risk of hospitalization for heart failure in patients with type 2 diabetes newly treated with DPP-4 inhibitors or other oral glucose-lowering medications: a retrospective … GP Fadini, A Avogaro, L Degli Esposti, P Russo, S Saragoni, S Buda, ... European heart journal 36 (36), 2454-2462, 2015 | 105 | 2015 |
The relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosis: a monthly MRI study after triple-dose gadolinium-DTPA A Paolillo, MC Piattella, P Pantano, S Di Legge, F Caramia, P Russo, ... Journal of neurology 251, 432-439, 2004 | 92 | 2004 |
Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS V Tomassini, L De Giglio, M Reindl, P Russo, I Pestalozza, P Pantano, ... Multiple Sclerosis Journal 13 (9), 1086-1094, 2007 | 86 | 2007 |
Time to market and patient access to new oncology products in Italy: a multistep pathway from European context to regional health care providers P Russo, FS Mennini, PD Siviero, G Rasi Annals of oncology 21 (10), 2081-2087, 2010 | 84 | 2010 |
Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in … V Gebbia, E Maiello, F Giuliani, N Borsellino, M Caruso, G Di Maggio, ... Annals of Oncology 18, vi124-vi127, 2007 | 75 | 2007 |
How aligned are the perspectives of EU regulators and HTA bodies? A comparative analysis of regulatory‐HTA parallel scientific advice G Tafuri, M Pagnini, J Moseley, M Massari, F Petavy, A Behring, A Catalan, ... British journal of clinical pharmacology 82 (4), 965-973, 2016 | 68 | 2016 |
Predictors of quality of life among patients with multiple sclerosis: an Italian cross-sectional study F Patti, P Russo, A Pappalardo, F Macchia, L Civalleri, A Paolillo, ... Journal of the neurological sciences 252 (2), 121-129, 2007 | 66 | 2007 |
Monitoring registries at Italian Medicines Agency: fostering access, guaranteeing sustainability S Montilla, E Xoxi, P Russo, A Cicchetti, L Pani International journal of technology assessment in health care 31 (4), 210-213, 2015 | 60 | 2015 |
Small animal imaging facility: new perspectives for the radiologist R Grassi, C Cavaliere, S Cozzolino, L Mansi, S Cirillo, G Tedeschi, ... La radiologia medica 114 (1), 152-167, 2009 | 50 | 2009 |
Television viewing and personality structure in children C Persegani, P Russo, C Carucci, M Nicolini, LL Papeschi, M Trimarchi Personality and individual differences 32 (6), 977-990, 2002 | 49 | 2002 |
Advanced age and medication prescription: more years, less medications? A nationwide report from the Italian Medicines Agency G Onder, A Marengoni, P Russo, L Degli Esposti, M Fini, A Monaco, ... Journal of the American Medical Directors Association 17 (2), 168-172, 2016 | 45 | 2016 |
Proposta di linee guida per la valutazione economica degli interventi sanitari G Aguzzi, G Baio, S Capri, M Cavazza, A Cicchetti, C Cislaghi, ... Politiche sanitarie 10 (2), 83-93, 2009 | 44 | 2009 |
OsMed Health-DB Network. Risk of hospitalization for heart failure in patients with type 2 diabetes newly treated with DPP-4 inhibitors or other oral glucose-lowering … GP Fadini, A Avogaro, L Degli Esposti, P Russo, S Saragoni, S Buda, ... Eur Heart J 36 (36), 2454-62, 2015 | 41 | 2015 |
The impact of parallel regulatory–health technology assessment scientific advice on clinical development. Assessing the uptake of regulatory and health technology assessment … G Tafuri, I Lucas, S Estevão, J Moseley, A d'Andon, H Bruehl, E Gajraj, ... British Journal of Clinical Pharmacology 84 (5), 1013-1019, 2018 | 40 | 2018 |
Mitoxantrone treatment in patients with early relapsing-remitting multiple sclerosis E Cocco, P Marchi, C Sardu, P Russo, A Paolillo, MG Mascia, M Solla, ... Multiple Sclerosis Journal 13 (8), 975-980, 2007 | 39 | 2007 |
The Italian Multiple Sclerosis Database Network (MSDN): the risk of worsening according to IFNβ exposure in multiple sclerosis M Trojano, P Russo, A Fuiani, D Paolicelli, E Di Monte, E Granieri, ... Multiple Sclerosis Journal 12 (5), 578-585, 2006 | 38 | 2006 |